✦ LIBER ✦

Impairment of drug metabolism in patients with liver cancer

✍ Scribed by EERO A. SOTANIEMI; R. OLAVI PELKONEN; RISTO E. MOKKA; RISTO HUTTUNEN; EILA VILJAKAINEN

Book ID: 114725829
Publisher: John Wiley and Sons
Year: 1977
Tongue: English
Weight: 486 KB
Volume: 7
Category: Article
ISSN: 0014-2972
DOI: 10.1111/j.1365-2362.1977.tb01604.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impairment of hepatic drug metabolism in

Impairment of hepatic drug metabolism in patients with acute viral hepatitis

✍ A. P. S. Narang; D. V. Datta; N. Nath; V. S. Mathur 📂 Article 📅 1982 🏛 Springer-Verlag 🌐 English ⚖ 508 KB

Impairment of drug metabolism in polycys

Impairment of drug metabolism in polycystic non-parasitic liver disease.

✍ EA Sotaniemi; PV Luoma; PM Jarvensivu; KA Sotaniemi 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 679 KB

The inhibition of drug metabolism by cim

The inhibition of drug metabolism by cimetidine in patients with liver cirrhosis

✍ Gugler, R. ;Wolf, M. ;Hansen, H. -H. ;Jensen, J. C. 📂 Article 📅 1984 🏛 Springer-Verlag 🌐 English ⚖ 513 KB

Enhancement of hepatic drug metabolism b

Enhancement of hepatic drug metabolism by glutethimide in patients with liver disease

✍ G. C. Farrell; W. G. E. Cooksley; L. W. Powell 📂 Article 📅 1979 🏛 Springer 🌐 English ⚖ 513 KB

Impairment of hepatic drug metabolism in

Impairment of hepatic drug metabolism in alcoholics.

✍ AW Harman; DB Frewin; BG Priestly; CB Alexander 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 534 KB

Antipyrine metabolism in patients with l

Antipyrine metabolism in patients with liver metastases from colorectal cancer

✍ Antonio Grieco; Carlo Barone; Paola Coletta; Rosario Castellano; Enzo Ragazzoni; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB 👁 2 views

## Background: The influence of cancer on antipyrine metabolism is under debate. ## Methods: To assess the functional activity of a liver with solid metastases from primary colorectal cancer, antipyrine metabolism was studied after the drug was administered orally (18 mg/kg body weight) to 55 hea